UNSPSC 51112204: Ifosfamide/mesna

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AN100. This VA Drug Class (AN100) classifies this compound as belonging to the group ANTINEOPLASTICS, ALKYLATING AGENTS.

UNSPSC 51112204 Ifosfamide/mesna, a Commodity code, represents pharmaceutical products procured by state health agencies and related public health benefit programs. The recent state and local activity under this code reflects demand for cancer chemotherapy agents and supportive pharmaceuticals used in treatment protocols, with procurement spanning both traditional pharmacy benefit acquisition and emerging direct-to-manufacturer distribution models.

The Texas Health and Human Services Commission posted Request for Information HHS0017013 in April 2026 to explore vendor capabilities for implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. This RFI sought information from vendors and stakeholders about establishing direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers to improve prescription fulfillment and cost management. The RFI requested detailed responses regarding vendors' experience with direct contracting for self-insured employers and health plans in both private and government sectors within the past two years, their flexibility to negotiate contracts based on negotiated net pricing models without rebates, and their capability to implement value-based or outcomes-based agreements. The Texas HHS Commission is conducting market intelligence to inform future procurement strategy and program design before issuing a formal Request for Proposal, with no award values, budget ranges, or set-aside designations identified at this exploratory stage.